| Not Yet Recruiting | Trial of JYB1904 Injection in Adolescent Participants Allergic Diseases | Phase 1 | 2026-05-17 |
| Not Yet Recruiting | Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis Perennial Allergic Rhinitis | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria. Chronic Spontaneous Urticaria | Phase 3 | 2026-03-31 |
| Not Yet Recruiting | A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults ADPKD (Autosomal Dominant Polycystic Kidney Disease) | Phase 1 | 2026-03-27 |
| Not Yet Recruiting | Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers ADPKD (Autosomal Dominant Polycystic Kidney Disease) | Phase 1 | 2026-03-18 |
| Not Yet Recruiting | Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSC NSCLC (Non-small Cell Lung Cancer) | Phase 3 | 2025-12-31 |
| Not Yet Recruiting | Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 1 | 2025-10-30 |
| Recruiting | A Study of JMKX005425 in Patients With MSI-H/dMMR Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2025-10-22 |
| Recruiting | A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutat NSCLC (Advanced Non-small Cell Lung Cancer) | Phase 1 | 2025-06-06 |
| Not Yet Recruiting | A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema Cardiac Edema | Phase 2 | 2025-06-01 |
| Recruiting | Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADP ADPKD (Autosomal Dominant Polycystic Kidney Disease) | Phase 2 | 2025-03-13 |
| Not Yet Recruiting | Study of JMKX003948 Ophthalmic Suspension in Healthy Participants Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME) | Phase 1 | 2025-02-01 |
| Recruiting | A Dose-finding Study of JMKX003142 in Treatment of Renal Edema Edema Secondary, Edema Leg | Phase 2 | 2025-01-07 |
| Recruiting | Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperp Hyperphosphatemia | Phase 2 | 2024-12-30 |
| Recruiting | A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion Malignant Pleural Effusions (Mpe) | Phase 1 | 2024-12-28 |
| Not Yet Recruiting | Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects ADPKD (autosomal Dominant Polycystic Kidney Disease) | Phase 1 | 2024-11-05 |
| Recruiting | Trial of JMKX003801 in Healthy Participants Healthy | Phase 1 | 2024-08-17 |
| Recruiting | Trial of JYB1904 in Chronic Spontaneous Urticaria. Chronic Spontaneous Urticaria | Phase 2 | 2024-08-04 |
| Not Yet Recruiting | To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects Solid Tumor, Adult | Phase 1 | 2024-07-10 |
| Active Not Recruiting | Trial of JYB1904 in Patients With Allergic Asthma Allergic Asthma | Phase 2 | 2024-06-19 |
| Unknown | Study of JMKX003142 Injection in Chinese Healthy Subjects Healthy Adult | Phase 1 | 2024-04-10 |
| Unknown | Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects Solid Tumor, Adult | Phase 1 | 2024-04-01 |
| Recruiting | Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain Diabetic Peripheral Neuropathic Pain | Phase 2 | 2024-03-25 |
| Recruiting | A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma Renal Cell Carcinoma Metastatic | Phase 1 | 2024-03-14 |
| Unknown | JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus Lupus Erythematosus, Systemic | Phase 2 | 2023-09-21 |
| Completed | A DDI Study of JMKX000623 and Metformin Hydrochloride Healthy, Drug-Drug Interaction | Phase 1 | 2023-09-17 |
| Unknown | JYB1907 in Subjects With Advanced Solid Tumors Solid Tumor | Phase 1 | 2023-07-31 |
| Unknown | Phase 1 Clinical Study of JMKX003142 Tablets Safety and Tolerability | Phase 1 | 2023-07-06 |
| Completed | Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China Carcinoma, Basal Cell (BCC) | Phase 4 | 2023-06-21 |
| Unknown | A Phase I Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion Malignant Pleural Effusion | Phase 1 | 2023-05-22 |
| Unknown | Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy Subjects Safety and Tolerability | Phase 1 | 2023-05-09 |
| Completed | Study of JYB1904 (an Anti-immunoglobulin E Antibody) in Healthy Chinese Subjects Healthy | Phase 1 | 2022-05-07 |
| Unknown | Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis Chronic Kidney Disease Stage 3B, Chronic Kidney Disease stage4, Glomerulonephritis | Phase 4 | 2020-04-30 |